In 2018, Naples part, the challenge against breast cancer. You will experience a vaccine
The study will start in 2018, to Naples, and could represent a great milestone in the fight against breast cancer. It is a vaccine, the preliminary results of which were presented at Chicago, in the framework of the congress of the American Society of Clinical Oncology. In 2018, Naples part, the challenge against breast cancer. You will experience a vaccine. The study, highly innovative, provides for the administration of the vaccine Globo H-KLH as adjuvant therapy (i.e. immediately after the breast surgery) in women with metastatic “triple-negative” with the aim of increasing the healing rates of this subtype of breast cancer, high aggression. “The availability of the vaccine to Pascale – says professor Michelino De Laurentiis – promises to be a great opportunity for the patients with breast cancer have access to treatment, high innovativeness. The therapeutic vaccines aim to trigger an immune response highly specific against the tumor, in theory, potentially more effective and with fewer side effects”. The results will see the national Institute of tumors of Naples Fondazione Pascale in the first row since it will be the only facility oncology Italian to take part in the trial.
The post In 2018, Naples part, the challenge against breast cancer. You will experience a vaccine appeared first on The Boot Thinking.